GENESYS2023-10-012023-12-31 GENESYS2023-10-012023-12-31 GENESYS2023-10-012023-12-31in-bse-fin:OneOperatingExpenses01Member GENESYS2023-10-012023-12-31in-bse-fin:FourOperatingExpenses01Member GENESYS2023-12-31 GENESYS2023-10-012023-12-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member GENESYS2023-10-012023-12-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member GENESYS2023-10-012023-12-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member GENESYS2023-10-012023-12-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 506109 GENESYS NOTLISTED Genesys International Corporation Limited Equity 2023-04-01 2024-03-31 2024-02-14 2024-02-08 INR Lakhs Third quarter 17:00:00 20:15:00 2024-02-14 2024-02-14 Not applicable Single segment Geographical information system 2023-10-01 2023-12-31 Unaudited Consolidated 593350000.00 25342000.00 618692000.00 122480000.00 0.00 0.00 116618000.00 10877000.00 110575000.00 46550000.00 407100000.00 211592000.00 0.00 211592000.00 44899000.00 9453000.00 54352000.00 0.00 157240000.00 0.00 0.00 0.00 0.00 157240000.00 2136000.00 159376000.00 158550000.00 -1310000.00 160583000.00 -1207000.00 189176000.00 5 4.21 4.21 0.00 0.00 4.21 4.21 Notes to unaudited consolidated financial results: 1 The Group is engaged in providing advanced geospatial content and solutions including 3D mapping. 2 The Group operates only in one Segment i.e. GIS based services for the purpose of IND AS – 108 Segmental reporting, hence disclosure as per IND AS 108 'Operating Segment' is not required. 3 The consolidated financial results for the quarter ended December 31, 2023 have been duly reviewed by the Audit Committee and approved by the Board of Directors at its meeting held on February 14, 2024. The Statutory auditors of the Genesys International Corporation Limited ( The Holding Company ) have expressed an unmodified opinion on the above consolidated results. These unaudited Consolidated financial results have been prepared in accordance with the recognition and measurement principles provided in Indian Accounting Standard (Ind AS) 34 on 'Interim Financial Reporting', the provisions of the Companies Act, 2013 (the Act), as applicable and guidelines issued by the Securities and Exchange Board of India (SEBI) under SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, as amended. 4 The Board of Directors of the Holding Company in its meeting held on 19th December 2022, has, subject to necessary approvals of the shareholders and other relevant appropriate authorities, approved the Scheme of Amalgamation for merger of its Wholly Owned Subsidiary, Virtual World Spatial Technologies Private Limited (Transferor Company), with Genesys International Corporation Limited (Transferee Company). Accordingly, an application under section 230 to 232 of the Companies Act, 2013 had been filed with Hon’ble NCLT, Mumbai bench, and the same has been allowed with the directions inter-alia to convene the meetings of Creditors. 5 The Holding Company had provided for rental expenses relating to hiring equipment for period November 2022 to July 2023 amounting to Rs. 319.96 lakhs. However, based on final negotiations / discussion with the vendor, an amount of Rs. 319.96 lakhs has been reversed and accordingly an amount of Rs. 184.36 lakhs for the period November 2022 to March 2023 has disclosed as other income and Rs. 135.60 lakhs for the period April 2023 to July 2023 has been adjusted against project expenses. 6 Previous period/year figures have been re-grouped, re-arranged and re-classified wherever necessary to conform to current period's classification. Single segment 2023-04-01 2023-12-31 Unaudited Consolidated 1270704000.00 45663000.00 1316367000.00 349208000.00 0.00 0.00 341284000.00 24758000.00 332981000.00 137385000.00 1185616000.00 130751000.00 0.00 130751000.00 51678000.00 10838000.00 62516000.00 0.00 68235000.00 0.00 0.00 0.00 0.00 68235000.00 12793000.00 81028000.00 72226000.00 -3991000.00 84646000.00 -3618000.00 189176000.00 5 1.91 1.91 0.00 0.00 1.91 1.91 Other Expenses 46550000.00 Other Expenses 137385000.00 Remeasurement of the net defined benefit liability / asset (net of taxes) 465000.00 Remeasurement of the net defined benefit liability / asset (net of taxes) 1392000.00 465000.00 1392000.00 0.00 0.00 Exchange differences on translation of financial statements of foreign operations 1671000.00 Exchange differences on translation of financial statements of foreign operations 11401000.00 1671000.00 11401000.00 0.00 0.00